文献速递胸部肿瘤放疗放疗物理与技术

窦房结剂量与中央型肺癌根治性立体定向体部放疗患者更差生存相关

Sinoatrial Node Dose Is Associated With Worse Survival in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Cancers.
PubMed 文献 · Pract Radiat Oncol · 2023-10-05

单机构回顾性研究纳入2007年2月至2021年12月接受根治性SBRT的中央型非小细胞肺癌患者93例,勾画窦房结和房室结并计算Dmax与Dmean。多因素Cox回归显示窦房结Dmax截止值1309 cGy(HR 2.03,P=0.026)和Dmean截止值836 cGy(HR 2.22,P=0.011)与总生存显著相关,房室结参数与生存无关。

要点

  • 窦房结Dmax截止值1309 cGy与更差总生存显著相关(HR 2.03)。
  • 窦房结Dmean截止值836 cGy与更差总生存显著相关(HR 2.22)。
  • 房室结剂量参数与生存结局无关联。

核心结论

  • 对于接受SBRT的非小细胞肺癌患者,窦房结Dmax和Dmean分别以1309和836 cGy为截止值时与更差总生存显著相关。
  • 作者认为需要进一步研究 examining SBRT期间窦房结照射的影响。

研究设计与样本

  • 单机构回顾性综述,纳入2007年2月至2021年12月因中央型胸部肿瘤接受根治性SBRT的原发性非小细胞肺癌患者。
  • 按已发表的勾画图谱勾画窦房结和房室结,计算每个结构的最大剂量(Dmax)和平均剂量(Dmean)。
  • 采用第50至90百分位之间的序贯log rank检验确定剂量参数与总生存的潜在截止值。
  • 共93例符合条件的患者,中位年龄72.5岁(IQR 66.6-78.3),中位随访32.4个月(IQR 13.0-49.6)。

主要发现

  • 窦房结Dmax中位值为95 cGy(范围9-5394),Dmean中位值为58 cGy(范围7-3168)。
  • 房室结Dmax中位值为45 cGy(范围4-2121),Dmean中位值为34 cGy(范围3-1667)。
  • 窦房结Dmax和Dmean的候选截止值分别为1309和836 cGy。
  • 未发现房室结参数与生存结局之间的关联。
  • 多因素Cox回归显示窦房结Dmax截止值(HR 2.03 [1.09-3.79];P=0.026)和Dmean截止值(HR 2.22 [1.20-4.12];P=0.011)与总生存显著相关。

关键数值与推荐

  • 窦房结Dmax截止值1309 cGy与更差总生存相关(HR 2.03 [1.09-3.79];P=0.026)。
  • 窦房结Dmean截止值836 cGy与更差总生存相关(HR 2.22 [1.20-4.12];P=0.011)。
  • 非癌症相关生存:窦房结Dmax截止值HR 2.02 [0.89-4.57](P=0.092),Dmean截止值HR 2.34 [1.05-5.18](P=0.037)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。
  • 作者在结论中提出需要进一步研究 examining SBRT期间窦房结照射的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Our purpose was to evaluate the clinical consequences of sinoatrial node (SAN) and atrioventricular node (AVN) irradiation in patients undergoing stereotactic body radiation therapy (SBRT) for central non-small cell lung cancer (NSCLC) tumors. METHODS AND MATERIALS: A single-institutional retrospective review of patients with primary NSCLC undergoing definitive SBRT for centrally located thoracic tumors from February 2007 to December 2021 was performed. The SAN and AVN were contoured in accordance with a published contouring atlas, and the maximum dose (Dmax) and mean dose (Dmean) for each structure were calculated. Sequential log rank testing between the 50th and 90th percentiles was used to identify potential cutoff values for the corresponding dosimetric parameters and overall survival. RESULTS: Among 93 eligible patients, the median age was 72.5 years (IQR, 66.6-78.3), and median follow-up was 32.4 months (IQR, 13.0-49.6). The median SAN Dmax and Dmean were 95 cGy (range, 9-5394) and 58 cGy (range, 7-3168), respectively. The median AVN Dmax and Dmean were 45 cGy (range, 4-2121) and 34 cGy (range, 3-1667), respectively. Candidate cutoff values for SAN Dmax and Dmean were 1309 and 836 cGy, respectively. No associations between AVN parameters and survival outcomes were identified. Upon multivariate Cox regression, the SAN Dmax cutoff (hazard ratio [HR], 2.03 [1.09-3.79]; P = .026) and SAN Dmean cutoff (HR, 2.22 [1.20-4.12]; P = .011) were significantly associated with overall survival. For noncancer-associated survival, the SAN Dmax cutoff trended toward significance (HR, 2.02 [0.89-4.57]; P = .092), and the SAN Dmean cutoff remained significantly associated (HR, 2.34 [1.05-5.18]; P = .037). CONCLUSIONS: For patients undergoing SBRT for NSCLC, SAN Dmax and Dmean were significantly associated with worse overall survival using cut-off values of 1309 and 836 cGy, respectively. Further studies examining the effect of SAN irradiation during SBRT are warranted.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Iovoli AJ, Yu H, Advani PG, et al. Sinoatrial Node Dose Is Associated With Worse Survival in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Cancers. Pract Radiat Oncol. 2023. PMID: 37804882. doi:10.1016/j.prro.2023.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。